Minimally invasive versus conventional surgical aortic valve replacement: retrospective multicentre-study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025211

Enrollment

5000

Registered

2021-05-20

Start date

2020-11-18

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I35.0

Interventions

Group 1: surgical aortic valve replacement via median sternotomy Group 2: surgical aortic valve replacement via partial sternotomy Group 3: surgical aortic valve replacement via lateral mini-thoracoto

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Adult men and women (>= 18 years) - Indication for surgery: aortic valve vitium - Possibly additional procedures: supracommissural replacement of ascending aorta, atrial ablation, resection of left atrial appendage, subvalvular resection (Morrows operation). - Informed consent to study participation (given during follow up visitation)

Exclusion criteria

Exclusion criteria: - Emergency operation - Re-operation - Endocarditis - Combined surgery other than above-mentioned - Denial or inability of consent to study participation

Design outcomes

Primary

Measure	Time frame
MACCE (death, myocardial infarction, stroke, reoperation) after 30 days an in follow-up (up to 5 years); questionnaire and telephone interview	—

Secondary

Measure	Time frame
blood transfusion, conversion to sternotomy, sternal wound healing disorder/ infection, postpericardiotomy syndrome, length of hospital stay, rehospitalisation	—

Countries

Germany

Contacts

Public ContactNora Göbel

Robert-Bosch-Krankenhaus

nora.goebel@rbk.de+49 711 8101 3650

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026